Abstract

Deep neural networks have led to state-of-the-art results in many medical imaging tasks including Alzheimer's disease (AD) detection based on structural magnetic resonance imaging (MRI) data. However, the network decisions are often perceived as being highly non-transparent, making it difficult to apply these algorithms in clinical routine. In this study, we propose using layer-wise relevance propagation (LRP) to visualize convolutional neural network decisions for AD based on MRI data. Similarly to other visualization methods, LRP produces a heatmap in the input space indicating the importance/relevance of each voxel contributing to the final classification outcome. In contrast to susceptibility maps produced by guided backpropagation (“Which change in voxels would change the outcome most?”), the LRP method is able to directly highlight positive contributions to the network classification in the input space. In particular, we show that (1) the LRP method is very specific for individuals (“Why does this person have AD?”) with high inter-patient variability, (2) there is very little relevance for AD in healthy controls and (3) areas that exhibit a lot of relevance correlate well with what is known from literature. To quantify the latter, we compute size-corrected metrics of the summed relevance per brain area, e.g., relevance density or relevance gain. Although these metrics produce very individual “fingerprints” of relevance patterns for AD patients, a lot of importance is put on areas in the temporal lobe including the hippocampus. After discussing several limitations such as sensitivity toward the underlying model and computation parameters, we conclude that LRP might have a high potential to assist clinicians in explaining neural network decisions for diagnosing AD (and potentially other diseases) based on structural MRI data.

Highlights

  • In the 2018 World Alzheimer Report, it was estimated that 50 million people worldwide were suffering from dementia and this number was projected to rise to more than 152 million people until 2050

  • The primary goal of Alzheimer’s Disease Neuroimaging Initiative (ADNI) has been to test whether serial magnetic resonance imaging (MRI), positron emission tomography (PET), other biological markers, and clinical and neuropsychological assessment can be combined to measure the progression of mild cognitive impairment (MCI) and early Alzheimer’s disease (AD)

  • Whereas Guided Backpropagation (GB) heatmaps are very susceptible for both AD and healthy controls (HCs), layer-wise relevance propagation (LRP) heatmaps show much more relevance in AD patients than HCs

Read more

Summary

Introduction

In the 2018 World Alzheimer Report, it was estimated that 50 million people worldwide were suffering from dementia and this number was projected to rise to more than 152 million people until 2050. Those markers have frequently been employed in machine learning settings to allow for predictions on an individual level (Klöppel et al, 2008; Orrù et al, 2012; Weiner et al, 2013; Ritter et al, 2015, 2016). Those expert features usually reflect only one part of disease pathology and the combination with standard machine learning methods, such as support vector machines, do not allow for finding new and potentially unexpected hidden data characteristics that might be important to describe a disease

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call